13F

AHCO ADAPTHEALTH CORP

2026Q1 · CUSIP 00653Q102 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
239
Δ holders QoQ
+8
Breadth percentile
Top 34%
Whale holders
126
Δ whales
+2
Inst. holding value
$1.7B
New positions
46
Closed positions
38
Price momentum (1Q)
+4.1%
Put / Call
5/4

Breadth history (34 quarters)

2019Q4: Δ+22 · h=24 2020Q1: Δ+12 · h=36 2020Q2: Δ+17 · h=53 2020Q3: Δ+26 · h=79 2020Q4: Δ+57 · h=136 2021Q1: Δ+11 · h=147 2021Q2: Δ-9 · h=138 2021Q3: Δ+3 · h=141 2021Q4: Δ+11 · h=152 2022Q1: Δ+2 · h=154 2022Q2: Δ-4 · h=150 2022Q3: Δ+33 · h=183 2022Q4: Δ+13 · h=196 2023Q1: Δ-24 · h=172 2023Q2: Δ+8 · h=180 2023Q3: Δ+12 · h=192 2023Q4: Δ+1 · h=193 2024Q1: Δ+19 · h=212 2024Q2: Δ-3 · h=209 2024Q3: Δ+9 · h=218 2024Q4: Δ-15 · h=203 2025Q1: Δ+23 · h=226 2025Q2: Δ-8 · h=218 2025Q3: Δ+6 · h=224 2025Q4: Δ+7 · h=231 2026Q1: Δ+8 · h=239 2019Q4: holders=24 2020Q1: holders=36 2020Q2: holders=53 2020Q3: holders=79 2020Q4: holders=136 2021Q1: holders=147 2021Q2: holders=138 2021Q3: holders=141 2021Q4: holders=152 2022Q1: holders=154 2022Q2: holders=150 2022Q3: holders=183 2022Q4: holders=196 2023Q1: holders=172 2023Q2: holders=180 2023Q3: holders=192 2023Q4: holders=193 2024Q1: holders=212 2024Q2: holders=209 2024Q3: holders=218 2024Q4: holders=203 2025Q1: holders=226 2025Q2: holders=218 2025Q3: holders=224 2025Q4: holders=231 2026Q1: holders=239 -57 -28.5 +0 +28.5 +57 21136251 19Q420Q321Q222Q122Q423Q324Q225Q125Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 7 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 9% +5.1% +3.8%
2024Q1 Top 16% +6.5% -3.4%
2023Q3 Top 15% -12.6% +19.4%
2022Q3 Top 2% +3.5% -48.7%
2020Q4 Top 10% -25.3% -24.0%
2020Q3 Top 9% +7.1% -18.0%
2020Q1 Top 7% +32.8% +80.5%

Options Sentiment

Put holders
5
QoQ: -4
Call holders
4
QoQ: -3

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.59
EPS YoY
-201.7%
Revenue (TTM)
$3.3B
Revenue YoY
+1.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $728M 2022-09-30: $756M 2022-12-31: $780M 2023-03-31: $745M 2023-06-30: $793M 2023-09-30: $804M 2023-12-31: $858M 2024-03-31: $792M 2024-06-30: $806M 2024-09-30: $806M 2024-12-31: $857M 2025-03-31: $778M 2025-06-30: $800M 2025-09-30: $820M 2025-12-31: $846M 2026-03-31: $820M 2022-06-30: EPS 0.09 2022-09-30: EPS 0.11 2022-12-31: EPS 0.05 2023-03-31: EPS -0.06 2023-06-30: EPS 0.09 2023-09-30: EPS -3.43 2023-12-31: EPS -1.91 2024-03-31: EPS -0.02 2024-06-30: EPS 0.13 2024-09-30: EPS 0.15 2024-12-31: EPS 0.35 2025-03-31: EPS -0.05 2025-06-30: EPS 0.10 2025-09-30: EPS 0.16 2025-12-31: EPS -0.73 2026-03-31: EPS -0.12 0M 429M 858M $M -3.77 -1.69 0.39 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 17 2023-03-31: PE 59.12023-06-30: PE 70.92024-12-31: PE 14.42025-03-31: PE 15.62025-06-30: PE 17.22025-09-30: PE 16.4 13 44 74 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)